Novel phosphodiesterase inhibitors

Details for Australian Patent Application No. 2008221121 (hide)

Owner Leo Pharma A/S

Inventors Felding, Jakob; Babu, Bollu Ravindra; Larsen, Jens Christian Hojland; Nielsen, Simon Feldbaek

Agent Callinan

Pub. Number AU-A-2008221121

PCT Pub. Number WO2008/104175

Priority 60/946,849 28.06.07 US; 60/903,849 28.02.07 US

Filing date 26 February 2008

Wipo publication date 4 September 2008

International Classifications

C07D 491/10 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/36 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 493/10 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

C07D 495/10 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

3 September 2009 PCT application entered the National Phase

  PCT publication WO2008/104175 Priority application(s): WO2008/104175

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008221143

2008221119-Method for cloning cognate antibodies